Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (2929)	1/25/2011 1:31:47 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3158

We have been talking for DECADES about using GM-CSF as a cancer vaccine adjuvant, many, many posts on several different threads. Such discussion was a mainstay on the Cistron thread, for example. :-) Message 10956774 (an example.... this concept ain't exactly NEW!) Anyway...... there's a company in Australia that is using a retroviral "vaccine", and a trickle of patients have trooped there over the years and reported back with amazing anecdote. Over the years, AMGN is right up there with OSIP, success of in-licensing (Immunex excepted, obviously).